← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Sujana Biotech, Llc
Cleveland, OH
$1,024,213
Total funding
2
Grants
Funding over time
peak $445.1K · FY2017–19$500K$375K$250K$125K$0
'17
'18
'19
Funding mix
By agency
NIH$1,024,213 · 2
By mechanism
N01$805,184 · 1
R43$219,029 · 1
Investigators at Sujana Biotech, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
IGF::OT::IGF VITA 2 - DEVELOPING AN ANTI-THROMBOTIC MONOCLONAL ANTIBODY (MAB) WITH IMPROVED SAFETY AND EFFICACY$383,867
N01 · FY2017 · HL
DEVELOPING AN ANTI-THROMBOTIC MONOCLONAL ANTIBODY (MAB) WITH IMPROVED SAFETY AND EFFICACY, VITA 2$226,023
N01 · FY2018 · HL
Selective Inhibition of Platelet GPIb-alpha Binding to Leukocyte Mac-1 as a Therapeutic for Multiple Sclerosis$219,029
R43 · FY2018 · NS
IGF::OT::IGF VITA 2 - DEVELOPING AN ANTI-THROMBOTIC MONOCLONAL ANTIBODY (MAB) WITH IMPROVED SAFETY AND EFFICACY$195,294
N01 · FY2019 · HL